Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
GOLD ROCK HOLDINGS, INC.Gold Rock Holdings Reports $138,000 Revenue in Fiscal Year 2024, Despite Net Loss
COMMERCIAL METALS CoCommercial Metals Company Reports Decline in Financial Performance for Q2 Fiscal 2025
Atlantis Glory Inc.Atlantis Glory Inc. Reports No Revenue and Net Loss Reduction for 2024
Carnival Corp Ltd.Carnival Corporation Reports 7.5% Revenue Increase to $5.81 Billion, Net Loss Improves
AMERICAN BATTERY MATERIALS, INC.American Battery Materials Reports $4.3 Million Net Loss for Fiscal Year 2024
Zoned Properties, Inc.Zoned Properties Reports 31.4% Revenue Growth to $3.79 Million for Fiscal Year 2024
RUM Group Inc.Rumble Inc. Reports 18% Revenue Growth to $95.5 Million Despite Increased Net Loss
Aprea Therapeutics, Inc.Aprea Therapeutics Reports $12.96 Million Net Loss for 2024, Grant Revenue Increases
ENERGY FOCUS, INC/DEEnergy Focus Reports $1.6 Million Net Loss for Fiscal Year 2024, Revenue Declines 15%
CorMedix Inc.CorMedix Reports $43.5 Million Revenue from DefenCath Launch in 2024
TON Strategy CoVerb Technology Reports 1,321% Revenue Growth to $895,000 in 2024
Argo Group International Holdings, Inc.Argo Group Reports 31.6% Decline in Gross Written Premiums and $210.1 Million Net Loss
ATOSSA THERAPEUTICS, INC.Atossa Therapeutics Reports $25.5 Million Net Loss for Fiscal Year 2024
Greater Cannabis Company, Inc.Greater Cannabis Company Reports No Revenue for Fiscal Year 2024, Narrows Net Loss
Kezar Life Sciences, Inc.Kezar Life Sciences Reports $83.7 Million Net Loss for 2024, Down from $101.9 Million in 2023
Core & Main, Inc.Core & Main Reports 11% Revenue Growth to $7.44 Billion for Fiscal Year Ending February 2025
KIORA PHARMACEUTICALS INCKiora Pharmaceuticals Reports $3.6 Million Net Income in 2024 Fiscal Year
Zura Bio LtdZura Bio Reports $45.4 Million Net Loss for Fiscal Year 2024, Improved from $69.2 Million in 2023
EQUATOR Beverage CoEQUATOR Beverage Company Reports 42% Revenue Growth to $3.26 Million for Fiscal Year 2024
Immix Biopharma, Inc.Immix Biopharma Reports $21.7 Million Net Loss for 2024, Highlights Clinical Advancements
Compass Digital Acquisition Corp.Compass Digital Acquisition Corp. Reports $3.5 Million Net Loss and Extends Business Combination Period
GLOBALINK INVESTMENT INC.Globalink Investment Inc. Reports $978,445 Net Loss for Fiscal Year 2024 Amid Merger Agreement with Alps Holdco
KHEOBA CORP.Kheoba Corp. Reports No Revenue and Significant Losses in Latest 10-Q Filing
Stellus Capital Investment CorpStellus Capital Investment Corporation Reports Financial Performance for Year Ended December 31, 2024
Serina Therapeutics, Inc.Serina Therapeutics Reports Significant Revenue Decline and Net Loss for Fiscal Year 2024